About Us

Our Company

 

cardioCytomedix, Inc. is an autologous regenerative therapies company commercializing innovative platelet technologies for orthopedics and wound care, with a pipeline of adult stem cell therapies for tissue repair. The Company markets the AutoloGel™ System, a device for the production of autologous platelet rich plasma (“PRP”) gel for use on a variety of exuding wounds. Our development pipeline of autologous regenerative cell therapies utilizes proprietary ALDH Bright Cell ("ALDHbr") technology to isolate biologically active pluri-potent stem cells for therapeutic use. A Phase 2 trial for the treatment of ischemic stroke using our ALDHbr Bright Cells is underway.